An abscess is a collection of pus that develops within tissues in the body as the result of a bacterial infection. The most common types of abscesses include skin abscesses, lung abscesses and brain abscesses. Abscesses are usually painful, swollen bumps under the skin that contain pus and dead white blood cells. Treatment for abscesses may involve drainage, antibiotics and in some severe cases, surgery. The global abscess treatment market comprises of products such as antibiotics and pain medicines which are used to treat abscesses arising from bacterial and fungal infections. The rising prevalence of skin infections around the world has boosted the need for effective abscess treatment solutions over the past few years.
The abscess treatment market is estimated to be valued at USD 3.42 Bn in 2024 and is expected to reach USD 5.45 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.88% from 2024 to 2031.
Key Takeaways
Key players operating in the abscess treatment market are Pfizer, GlaxoSmithKline, Novartis, Sanofi and Abbott.
The rising awareness about early abscess detection and management presents significant growth opportunities for players in this Abscess Treatment Market. Additionally, the increasing adoption of advanced antibiotics and pain relief products for fast healing also drives the demand.
The major players are focusing on geographic expansion strategies across Asia Pacific, Latin America, Middle East and Africa to tap the increasing healthcare demand in emerging nations. With rising disposable incomes, people in developing countries are able to spend more on healthcare and abscess treatment.
Market drivers
High disease prevalence is a major factor driving the abscess treatment market growth. Skin and soft tissue infections are common globally and rising at an alarming rate. As per some estimates, over 500,000 patients develop abscesses annually only in the US requiring immediate medical care. This large patient pool demands advanced treatment solutions.
Market restraints High cost of branded drugs and surgical procedures for severe abscess cases poses significant challenges. This limits their uptake in price-sensitive developing and underdeveloped markets. Additionally, complications arising due to incorrect self-diagnosis and medication non-adherence can hamper the market expansion over the forecast period.
Segment Analysis
The abscess treatment market can be segmented into dental abscess, skin abscess, and others. The dental abscess segment currently dominates the market owing to the high prevalence of dental caries and periodontal diseases. Dental abscess occurs due to dental infections arising from deep decay, gum disease, or infected tooth injuries. Improper dental hygiene habits leading to plaque formation increases the risk of dental abscess.
Global Analysis
North America holds the largest share in the abscess treatment market due to the growing prevalence of dental disorders, improved healthcare infrastructure, and favourable reimbursement policies in the region. Europe is also a significant market supported by government funding for innovation and research. However, Asia Pacific is expected to witness the highest growth over the forecast period owing to developing healthcare infrastructure, raising awareness about oral healthcare, and growing medical tourism in countries such as India and Thailand. Growing geriatric population prone to chronic diseases like diabetes that increase the risk of infections and abscesses will also propel the demand for abscess treatment in Asia Pacific region.
Get This Report in Japanese Language: 膿瘍治療市場
Get This Report in Korean Language: 농양 치료 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
